Bacteriophage production in compliance with regulatory requirements

Jean Paul Pirnay, Maia Merabishvili, Hilde Van Raemdonck, Daniel De Vos, Gilbert Verbeken

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

In this chapter we review bacteriophage production requirements to help institutions, which wish to manufacture bacteriophage products for human use in compliance with the applicable regulatory expectancies, defining production processes and implementing relevant controls ensuring quality, safety, and efficacy of the final products. The information disclosed in this chapter can also serve as a basis for discussions with competent authorities regarding the development of expedited bacteriophage product development and licensing pathways, including relevant and pragmatic requirements, and allowing for the full exploitation of bacteriophages as natural controllers of bacterial populations.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages233-252
Number of pages20
DOIs
Publication statusPublished - 2018

Publication series

NameMethods in Molecular Biology
Volume1693
ISSN (Print)1064-3745

Keywords

  • Antibiotic resistance
  • Bacteriophage therapy
  • Drug
  • Manufacturing
  • Medicinal product
  • Production
  • Quality and safety

Fingerprint

Dive into the research topics of 'Bacteriophage production in compliance with regulatory requirements'. Together they form a unique fingerprint.

Cite this